FOXO3 and cancer: The upregulation of FOXO3a contributed to G2/M arrest in RSL1D1-downregulated HCT116p53−/− cells, thereby inhibiting cell proliferation (Fig. 1C and D), which is consistent with the current opinion that FOXO3a activation induces G2/M arrest in various cancer cells [44–47].